The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.

[1]  Yolanda F. Darlington,et al.  Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair* , 2010, The Journal of Biological Chemistry.

[2]  Xiongbin Lu,et al.  Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response. , 2009, Cancer research.

[3]  P. Plevani,et al.  Checkpoint mechanisms at the intersection between DNA damage and repair. , 2009, DNA repair.

[4]  W. Chazin,et al.  Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A* , 2009, The Journal of Biological Chemistry.

[5]  Marketa Zvelebil,et al.  PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas , 2009, Clinical Cancer Research.

[6]  T. Nouspikel.  Nucleotide excision repair : variations on versatility , 2009 .

[7]  R. Rouget,et al.  ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells , 2008, Proceedings of the National Academy of Sciences.

[8]  K. Cimprich,et al.  ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.

[9]  K. Jan,et al.  Direct involvement of the tumor suppressor p53 in nucleotide excision repair. , 2008, DNA repair.

[10]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[11]  Yolanda F. Darlington,et al.  The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways , 2008, Cancer and Metastasis Reviews.

[12]  Xiongbin Lu,et al.  The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.

[13]  B. A. Ballif,et al.  ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.

[14]  Xinbin Chen,et al.  p53 modulation of the DNA damage response , 2007, Journal of cellular biochemistry.

[15]  Marie-Claude Marsolier-Kergoat,et al.  The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase , 2007, Oncogene.

[16]  Y. Zou,et al.  ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation , 2007, Oncogene.

[17]  E. Appella,et al.  Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.

[18]  L. Donehower,et al.  Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice , 2006, Molecular carcinogenesis.

[19]  N. Onishi,et al.  Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase , 2006, Cell Death and Differentiation.

[20]  Y. Zou,et al.  Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. , 2006, Cancer research.

[21]  Ludovic C. Gillet,et al.  Molecular mechanisms of mammalian global genome nucleotide excision repair. , 2006, Chemical reviews.

[22]  D. Hallahan,et al.  Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. , 2006, Cancer research.

[23]  Chen-Yang Shen,et al.  Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. , 2006, Cancer research.

[24]  Päivikki Kauraniemi,et al.  The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours , 2006, Breast Cancer Research and Treatment.

[25]  L. Donehower,et al.  PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.

[26]  L. Donehower,et al.  Reversal of the ATM/ATR-Mediated DNA Damage Response by the Oncogenic Phosphatase PPM1D , 2005, Cell cycle.

[27]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[28]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[29]  S. Durell,et al.  Substrate Specificity of the Human Protein Phosphatase 2Cδ, Wip1† , 2005 .

[30]  F. Gruijl,et al.  Powerful Skin Cancer Protection by a CPD-Photolyase Transgene , 2005, Current Biology.

[31]  J. Latimer,et al.  Analysis of DNA repair using transfection-based host cell reactivation. , 2005, Methods in molecular biology.

[32]  S. Durell,et al.  Substrate specificity of the human protein phosphatase 2Cdelta, Wip1. , 2005, Biochemistry.

[33]  W. Vermeulen,et al.  Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity , 2004, The EMBO journal.

[34]  L. Donehower,et al.  The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. , 2004, Molecular cell.

[35]  J. Inazawa,et al.  Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  Akira Nakagawara,et al.  PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.

[37]  Y. Shiloh.  ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[38]  J. Ford,et al.  p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Nakajima,et al.  Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice , 2002, The EMBO journal.

[40]  Jeffrey R. Marks,et al.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.

[41]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[42]  M. Christmann,et al.  Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity. , 2002, Nucleic acids research.

[43]  Y. Seo,et al.  p53 regulation of DNA excision repair pathways. , 2002, Mutagenesis.

[44]  Lawrence A. Donehower,et al.  Mice Deficient for the Wild-Type p53-Induced Phosphatase Gene (Wip1) Exhibit Defects in Reproductive Organs, Immune Function, and Cell Cycle Control , 2002, Molecular and Cellular Biology.

[45]  E. Friedberg.  How nucleotide excision repair protects against cancer , 2001, Nature Reviews Cancer.

[46]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[47]  Masaaki Adachi,et al.  p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.

[48]  Y. Shiloh,et al.  Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products , 2000, Nature.

[49]  P. Hanawalt,et al.  Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Wood,et al.  Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts. , 1996, Nucleic acids research.